Showing results (171-180 of 425) with videos related to

Sort By:
Pageof 43
Brain, Behavior, and Immunity|May 14, 2021
Environmental activation of a hypothalamic BDNF-adipocyte IL-15 axis regulates adipose-natural killer cellsStephen M Bergin, Run Xiao, Wei Huang, et al.
Blood|September 18, 2004
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBradley W Blaser, Sameek Roychowdhury, Daniel J Kim, et al.
Nature Immunology|January 19, 2023
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cellsShoubao Ma, Baofa Sun, Songqi Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2019
Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene TherapyRun Xiao, Anthony G Mansour, Wei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2015
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple MyelomaDon M Benson, Adam D Cohen, Sundar Jagannath, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
Blood|August 4, 2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemiaAndrew Mone, Shannon Puhalla, Susan Whitman, et al.
European Journal of Immunology|February 17, 2006
STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivoJeffrey B VanDeusen, Manisha H Shah, Brian Becknell, et al.
Blood|May 4, 2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiationJi Suk Chang, Ramasamy Santhanam, Rossana Trotta, et al.
Cancer Immunology Research|March 5, 2015
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine DevelopmentAlex S Hartlage, Tom Liu, John T Patton, et al.
Pageof 43